Syntax Research Inc. Acquires 6,637 Shares of Nutrien Ltd. (NYSE:NTR)

Syntax Research Inc. grew its holdings in shares of Nutrien Ltd. (NYSE:NTRFree Report) by 11.4% during the third quarter, according to its most recent 13F filing with the SEC. The institutional investor owned 64,836 shares of the company’s stock after buying an additional 6,637 shares during the period. Nutrien makes up 2.1% of Syntax Research Inc.’s investment portfolio, making the stock its 20th largest holding. Syntax Research Inc.’s holdings in Nutrien were worth $3,116,000 as of its most recent SEC filing.

Several other large investors also recently modified their holdings of the stock. Central Pacific Bank Trust Division acquired a new position in shares of Nutrien during the 3rd quarter valued at $28,000. Family Firm Inc. bought a new position in shares of Nutrien during the 2nd quarter worth about $32,000. Andra AP fonden acquired a new stake in shares of Nutrien in the 2nd quarter valued at about $51,000. Point72 Asia Singapore Pte. Ltd. bought a new stake in Nutrien in the 2nd quarter valued at about $52,000. Finally, Rothschild Investment LLC acquired a new position in Nutrien during the 2nd quarter worth approximately $72,000. Institutional investors and hedge funds own 63.10% of the company’s stock.

Nutrien Trading Down 1.1 %

NYSE NTR opened at $46.38 on Wednesday. The business’s fifty day moving average is $47.75 and its 200-day moving average is $48.80. The company has a debt-to-equity ratio of 0.38, a current ratio of 1.27 and a quick ratio of 0.82. The stock has a market capitalization of $22.84 billion, a price-to-earnings ratio of 31.13, a PEG ratio of 1.73 and a beta of 0.80. Nutrien Ltd. has a one year low of $44.65 and a one year high of $60.87.

Nutrien (NYSE:NTRGet Free Report) last announced its quarterly earnings data on Wednesday, November 6th. The company reported $0.39 EPS for the quarter, missing the consensus estimate of $0.43 by ($0.04). Nutrien had a return on equity of 6.99% and a net margin of 2.79%. The company had revenue of $5.35 billion during the quarter, compared to the consensus estimate of $5.26 billion. During the same period in the prior year, the firm posted $0.35 EPS. The business’s revenue was down 5.0% on a year-over-year basis. Equities research analysts predict that Nutrien Ltd. will post 3.5 EPS for the current year.

Nutrien Increases Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Friday, January 17th. Shareholders of record on Tuesday, December 31st will be issued a dividend of $0.939 per share. This represents a $3.76 annualized dividend and a yield of 8.10%. This is a positive change from Nutrien’s previous quarterly dividend of $0.54. The ex-dividend date is Tuesday, December 31st. Nutrien’s dividend payout ratio is 144.97%.

Analysts Set New Price Targets

A number of equities research analysts have commented on NTR shares. The Goldman Sachs Group cut Nutrien from a “buy” rating to a “neutral” rating and reduced their price objective for the company from $69.00 to $53.00 in a research note on Tuesday, September 10th. Raymond James upgraded shares of Nutrien from a “market perform” rating to an “outperform” rating and boosted their price target for the company from $58.00 to $60.00 in a research note on Tuesday, December 3rd. Royal Bank of Canada restated an “outperform” rating and set a $60.00 price objective on shares of Nutrien in a report on Friday, September 20th. Wells Fargo & Company downgraded shares of Nutrien from an “overweight” rating to an “equal weight” rating and decreased their target price for the stock from $62.00 to $50.00 in a research report on Tuesday, September 24th. Finally, Oppenheimer initiated coverage on shares of Nutrien in a report on Thursday, December 12th. They issued an “outperform” rating and a $60.00 target price on the stock. Three analysts have rated the stock with a sell rating, four have issued a hold rating and eleven have assigned a buy rating to the stock. According to data from MarketBeat, the stock presently has an average rating of “Hold” and a consensus price target of $58.95.

View Our Latest Stock Analysis on NTR

Nutrien Company Profile

(Free Report)

Nutrien Ltd. provides crop inputs and services. The company operates through four segments: Retail, Potash, Nitrogen, and Phosphate. The Retail segment distributes crop nutrients, crop protection products, seeds, and merchandise products. The Potash segment provides granular and standard potash products.

Featured Stories

Want to see what other hedge funds are holding NTR? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Nutrien Ltd. (NYSE:NTRFree Report).

Institutional Ownership by Quarter for Nutrien (NYSE:NTR)

Receive News & Ratings for Nutrien Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Nutrien and related companies with MarketBeat.com's FREE daily email newsletter.